Dr Robert Orme.
Consultant Intensivist, Cheltenham General Hospital.
Like many ‘jobbing’ intensivists I had always admired those
of us who managed to get involved in serious research and get their names in
the big journals. I’d also, on many an occasion, thought of important questions
that I felt really needed answering with a proper clinical trial but thought
that not being a proven researcher in an academic institution would render this
unachievable. That’s where the Intensive Care Society really can help, as my
experience of the research prioritisation exercise proves.
In 2007, around 5 patients with severe sepsis and myocardial
dysfunction on our ICU in Cheltenham received levosimendan after we’d read of
its promise in Andrea Morelli’s paper in Intensive Care Medicine. It seemed to
make a dramatic impact and all of our patients survived.